Stay updated on Study of ZN-c3 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of ZN-c3 in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record for the Phase 1 Azenosertib (ZN-c3) trial in participants with solid tumors is displayed, including its completed status, study design, eligibility criteria, locations, and outcome measures.
    Difference
    48%
    Check dated 2026-11-09T13:13:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:36:16.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice appears announcing updates to NIH websites and explaining that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:38:28.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T16:40:03.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T16:43:07.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content and indicating restricted access to the study record.
    Difference
    18%
    Check dated 2026-09-21T21:53:15.000Z thumbnail image

Stay in the know with updates to Study of ZN-c3 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of ZN-c3 in Solid Tumors Clinical Trial page.